Business
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Agreement to Deliver Critical Medicines ITASCA, Ill., Dec. 17, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a
About this update from Lakeside Holding Limited
[{"type":"text","content":"Agreement to Deliver Critical Medicines \nITASCA, Ill., Dec. 17, 2024 /PRNewswire/ -- Lakeside Holding Limited (\"Lakeside\" or the \"Company\") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that Hupan Pharmaceutical has signed a Sales Agreement (the \"Agreement\") with Sinopharm Holding Hubei New Special Medicine Co., Ltd. (\"Sinopharm Hubei\"), a subsidiary of Sinopharm Group. The Agreement, valued at approximately RMB 11.0 million (approximately $1.5 million), is effective from January 1, 2025, through the end of the year and involves the sale and delivery of critical medicines, including Sodium Bicarbonate, Glucose, and Glucose Sodium Chloride. \n\nThis Agreement follows the partnership with Sinopharm Group announced last month focusing on essential medicine storage, transportation, and logistics services. These achievements reflect Hupan Pharmaceutical's expanding role as a reliable provider of pharmaceutical solutions in China.\n\"We are excited to strengthen our relationship with Sinopharm Group further, a leading global player in the healthcare industry,\" said Lan Su, COO of Lakeside Holding Limited. \"This Agreement demonstrates our capabilities in delivering high-quality pharmaceutical products, ensuring reliable supplies of essential medicines. We remain committed to broadening our portfolio and expanding our market reach, enhancing our role as a trusted pharmaceutical solutions provider.\"\nAbout Lakeside Holding Limited\nLakeside Holding Limited is a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market. Through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.—Lakeside delivers tailored logistics solutions spanning general and specialized sectors.\nAmerican Bear Logistics, with strategic hubs in Chicago, Dallas, Los Angeles, and New York, offers customized cross-border ocean and airfreight solutions, connecting Asia-based logistics service companies and e-commerce platforms with the U.S. market.\nLakeside recently acquired Hupan Pharmaceutical (Hubei) Co., Ltd., expanding its service scope and enhancing its pharmaceutical logistics and distribution capabilities within China. This strategic move underscores Lakeside's commitment...